Shares of Novavax Inc. NVAX, -0.85% slumped 0.85% to $16.37 Monday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ Composite Index COMP, +1.26% rising 1.26% to 11,143.74 and the Dow Jones Industrial Average DJIA, +1.58% rising 1.58% to 34,005.04. This was the stock’s second consecutive day of losses. Novavax Inc. closed $220.13 below its 52-week high ($236.50), which the company reached on December 20th.
The stock underperformed when compared to some of its competitors Monday, as Johnson & Johnson JNJ, +1.19% rose 1.19% to $177.84, Pfizer Inc. PFE, +0.85% rose 0.85% to $52.16, and Merck & Co. Inc. MRK, +0.17% rose 0.17% to $108.97. Trading volume (2.5 M) remained 2.6 million below its 50-day average volume of 5.0 M.